| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2106 | 2003 |
| Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study A Giacomelli, L Pezzati, F Conti, D Bernacchia, M Siano, L Oreni, ... Clinical infectious diseases 71 (15), 889-890, 2020 | 1741 | 2020 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1488 | 2006 |
| Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010 | 1155 | 2010 |
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ... Jama 308 (4), 387-402, 2012 | 1152 | 2012 |
| ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV P Ferenci, D Bernstein, J Lalezari, D Cohen, Y Luo, C Cooper, E Tam, ... New England Journal of Medicine 370 (21), 1983-1992, 2014 | 999 | 2014 |
| COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? P Sarzi-Puttini, V Giorgi, S Sirotti, D Marotto, S Ardizzone, G Rizzardini, ... Clinical and experimental rheumatology 38 (2), 337-342, 2020 | 554 | 2020 |
| Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study HJ Stellbrink, C Orkin, JR Arribas, J Compston, J Gerstoft, ... Clinical Infectious Diseases 51 (8), 963-972, 2010 | 482 | 2010 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 398 | 2019 |
| Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression S Swindells, JF Andrade-Villanueva, GJ Richmond, G Rizzardini, ... New England Journal of Medicine 382 (12), 1112-1123, 2020 | 380 | 2020 |
| Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis A Gori, C Tincati, G Rizzardini, C Torti, T Quirino, M Haarman, K Ben Amor, ... Journal of clinical microbiology 46 (2), 757-758, 2008 | 290 | 2008 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study A Giacomelli, AL Ridolfo, L Milazzo, L Oreni, D Bernacchia, M Siano, ... Pharmacological research 158, 104931, 2020 | 276 | 2020 |
| Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an … G Rizzardini, D Eskesen, PC Calder, A Capetti, L Jespersen, M Clerici British journal of nutrition 107 (6), 876-884, 2012 | 274 | 2012 |
| Retinal findings in patients with COVID-19: Results from the SERPICO-19 study A Invernizzi, A Torre, S Parrulli, F Zicarelli, M Schiuma, V Colombo, ... EClinicalMedicine 27, 2020 | 262 | 2020 |
| Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non … ET Overton, G Richmond, G Rizzardini, H Jaeger, C Orrell, F Nagimova, ... The Lancet 396 (10267), 1994-2005, 2020 | 234 | 2020 |
| Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial A Gori, G Rizzardini, B Van't Land, KB Amor, J Van Schaik, C Torti, ... Mucosal immunology 4 (5), 554-563, 2011 | 222 | 2011 |
| Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment … S Antinori, MV Cossu, AL Ridolfo, R Rech, C Bonazzetti, G Pagani, ... Pharmacological research 158, 104899, 2020 | 221 | 2020 |
| Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima‐media thickness S Piconi, D Trabattoni, C Luraghi, E Perilli, M Borelli, M Pacei, ... The FASEB Journal 23 (4), 1196-1204, 2009 | 219 | 2009 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 218 | 2015 |
spinello antinoriProfessore ordinario di Malattie Infettive, Università degli Studi di MilanoVerified email at unimi.it
